Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/12805
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChanlalit W.
dc.contributor.authorTeeyapant C.
dc.contributor.authorSoodchuen S.
dc.date.accessioned2021-04-05T03:21:38Z-
dc.date.available2021-04-05T03:21:38Z-
dc.date.issued2018
dc.identifier.issn3405354
dc.identifier.other2-s2.0-85038406648
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/12805-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85038406648&doi=10.1007%2fs00415-017-8713-7&partnerID=40&md5=111fdd0d1a9503e93b77dc38f5e238d0
dc.description.abstractTrochlear pain is frequently overlooked as published data regarding the clinical characteristic and current treatment are limited. The aim of this study is to evaluate this information from our experiences with trochlear pain. Medical records of 43 patients with trochlear pain from HRH Princess Maha Chakri Sirindhorn Medical Center between November 2010 and April 2017 were reviewed. Most patients were female (88%), with a median age of 51 years. Common characteristic symptoms of trochlear pain were acute, episodic, dull or pressure-like, periorbital pain, often radiating to the forehead, and aggravated by eye movements, especially reading. The causes of trochlear pain were idiopathic or primary trochlear headache (n = 33, 77%) and trochleitis (n = 10, 23%). Treatments included oral NSAIDs or dexamethasone injection into the trochlear region. At a median follow-up of 11 months (range 0–64), 67% of the patients reported complete remission using oral medication. Local steroid injection is useful in non-responding patients to oral therapy with an overall remission of 86%. Successful treatment outcome was achieved in most patients. © 2017, Springer-Verlag GmbH Germany, part of Springer Nature.
dc.subjectdexamethasone
dc.subjectdiclofenac
dc.subjectibuprofen
dc.subjectindometacin
dc.subjectlidocaine
dc.subjectnaproxen
dc.subjectnonsteroid antiinflammatory agent
dc.subjectsteroid
dc.subjectadult
dc.subjectaged
dc.subjectArticle
dc.subjectBrown syndrome
dc.subjectclinical article
dc.subjectdiplopia
dc.subjectecchymosis
dc.subjecteye movement
dc.subjectfemale
dc.subjectfollow up
dc.subjectheadache
dc.subjecthuman
dc.subjectidiopathic disease
dc.subjectmale
dc.subjectmedical record review
dc.subjectmiddle aged
dc.subjectmigraine
dc.subjectnausea
dc.subjectpain
dc.subjectphotophobia
dc.subjectpriority journal
dc.subjectremission
dc.subjectretrospective study
dc.subjectsymptom
dc.subjecttension headache
dc.subjecttreatment outcome
dc.subjecttrochlear pain
dc.subjecttrochlear pain
dc.subjecttrochleitis
dc.subjectvery elderly
dc.subjectyoung adult
dc.subjectanalgesia
dc.subjectcomplication
dc.subjectcomputed tomography scanner
dc.subjectdiagnostic imaging
dc.subjectorbit
dc.subjectpain
dc.subjectpain measurement
dc.subjectprocedures
dc.subjecttreatment outcome
dc.subjecttrochlear nerve disease
dc.subjectAnti-Inflammatory Agents, Non-Steroidal
dc.subjectFemale
dc.subjectHumans
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectOrbit
dc.subjectPain
dc.subjectPain Management
dc.subjectPain Measurement
dc.subjectRetrospective Studies
dc.subjectSteroids
dc.subjectTomography Scanners, X-Ray Computed
dc.subjectTreatment Outcome
dc.subjectTrochlear Nerve Diseases
dc.titleTrochlear pain: clinical characteristics and treatment outcomes
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationJournal of Neurology. Vol 265, No.2 (2018), p.376-380
dc.identifier.doi10.1007/s00415-017-8713-7
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.